Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

July 24, 2017

Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs

News

Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs). The model, which researchers refer to as a “seizure-in-a-dish” model ... Read more

July 5, 2017

LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children

News

The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial onset epileptic seizures in children as young as 4, making it ... Read more

June 30, 2017June 30, 2017

Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates

News

The epilepsy therapy known as Zebinix in Europe and Aptiom in the United States does not impair cognition in children, a Phase 2 clinical trial indicates. Children with focal epilepsy who ... Read more

June 26, 2017June 26, 2017

LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans

News

The U.S. Food and Drug Administration has granted expanded approval to LivaNova’s VNS Therapy Systems for people with drug-resistant epilepsy that allows use with magnetic resonance imaging (MRI) of the brain, the ... Read more

June 9, 2017

Net Gains May Support Cost-effectiveness of Epilepsy Self-management Program, Study Suggests

News

A multicomponent self-management intervention for adults with epilepsy did not significantly improve disease-related quality of life or other disease-related measures compared to usual care in a clinical trial. Nevertheless, researchers ... Read more

June 5, 2017

Noninvasive Deep Brain Stimulation Can Become Reality, Mouse Study Shows

News

Researchers have, for the first time, showed that it is possible to stimulate structures deep within the brain without the need for implanted electrodes — opening the possibility that epilepsy patients could ... Read more

April 24, 2017

Cannabis Media Group Promotes RSHO-X Cannabidiol Oil for Epilepsy

News

The medical cannabis product cannabidiol oil — marketed as RSHO-X — is showing promise as an epilepsy treatment, according to CFN Media Group. The digital media network, dedicated to legal ... Read more

April 21, 2017

Zika Virus May Trigger Epilepsy, CDC Researchers Caution in Report

News

In addition to its well-known links to birth defects, Zika virus infection during pregnancy can cause epilepsy, according to a report from the U.S. Centers for Disease Control and Prevention ... Read more

March 31, 2017

Cannabis Product Reduces Epileptic Seizures in Lennox-Gastaut Syndrome, Study Shows

News

A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The study ... Read more

March 8, 2017

Blood Flow Abnormalities May Cause Neuronal Death and Cognitive Decline in Epilepsy

News

Not only abnormal stimulation kills brain neurons in epilepsy, new research shows. It appears that lack of oxygen caused by blood flow abnormalities triggers up to half of nerve cell deaths ... Read more